Important Dates

Quote
























I’d say this person knows something. Let me take a stab:
Dec.10-New Business unit leadership announced
Jan. 8-Deal closes
Feb.6-layoffs/cuts
March 11-new teams announced/meetings of new organization
 


















Division heads will be announced tomorrow but don’t be fooled into a false sense of security! Just because you recognize a name does not mean the entire division is safe.....There will be drastic cuts and reductions of 30-50% in most divisions. The division may survive; but you may not!
 






Instead of fantasizing about how you’re gonna get axed just start looking for another job. Plenty are hiring . No need to stress out if you prepare and line something up before the official word is given. Pocket your severance and move on
 












looks like OP was dead on with the dates. Combining nueroscience, OBU, and primary care just signals the death of the OBU. Prepare for the sell off. Hopefully its to a good company. Nuero and PC fit well together and OBU sticks out like a sore thumb.
 






anonymous said:
looks like OP was dead on with the dates. Combining nueroscience, OBU, and primary care just signals the death of the OBU. Prepare for the sell off. Hopefully its to a good company. Nuero and PC fit well together and OBU sticks out like a sore thumb.
Click to expand...

Each franchise will operate independently in the new business unit structure. Stop trying to stir thing up. You have no clue what you’re talking about.
 












the email said divest 10 billion. They also said the focus is GI and rare disease. Wouldnt auprise me if primary care, nuero, and OBU are all spun off. Group em together for a better deal.
 


















they’ll be spun off- actually the drugs will be sold not the BU’s. They have to Be bundled... Vyvanse has 4.5 years left nobody is going to buy it, we’ll maybe some $hit company that needs a quick couple hundred million like Neos or Supernus. Either way the entire Neuroscience field force or what is left is history. I figure they can get $1/$1.5 for Xiidra, maybe $6/$7 billion for Vyvanse. $100 mil for Mydayis... the. $500 mil for AXR. The rest they’ll make up with PC. It’s a no brainer, the ADHD market is dead when Vyvanse goes generic. I am glad I am out!!! You suckers who are sticking around will miss the boat if you wait till March
 


















anonymous said:
they’ll be spun off- actually the drugs will be sold not the BU’s. They have to Be bundled... Vyvanse has 4.5 years left nobody is going to buy it, we’ll maybe some $hit company that needs a quick couple hundred million like Neos or Supernus. Either way the entire Neuroscience field force or what is left is history. I figure they can get $1/$1.5 for Xiidra, maybe $6/$7 billion for Vyvanse. $100 mil for Mydayis... the. $500 mil for AXR. The rest they’ll make up with PC. It’s a no brainer, the ADHD market is dead when Vyvanse goes generic. I am glad I am out!!! You suckers who are sticking around will miss the boat if you wait till March
Click to expand...

Good for you that you are out and to make the decision to do. I was going to respond on your business case for the products... but actually...to you care ?
Enjoy !
 






Top Bottom
Back
Quote